- •Table of Contents
- •Copyright
- •Contributors
- •How to Use this Study Guide
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •4: Outcomes Research
- •Questions
- •Answers
- •5: Core Principles of Perioperative Care
- •Questions
- •Answers
- •Questions
- •Answers
- •7: Principles of Urologic Endoscopy
- •Questions
- •Answers
- •8: Percutaneous Approaches to the Upper Urinary Tract Collecting System
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •12: Infections of the Urinary Tract
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •15: Sexually Transmitted Diseases
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •20: Principles of Tissue Engineering
- •Questions
- •Answers
- •Questions
- •Answers
- •22: Male Reproductive Physiology
- •Questions
- •Answers
- •Questions
- •Answers
- •24: Male Infertility
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •28: Priapism
- •Questions
- •Answers
- •Questions
- •Answers
- •30: Surgery for Erectile Dysfunction
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •34: Neoplasms of the Testis
- •Questions
- •Answers
- •35: Surgery of Testicular Tumors
- •Questions
- •Answers
- •36: Laparoscopic and Robotic-Assisted Retroperitoneal Lymphadenectomy for Testicular Tumors
- •Questions
- •Answers
- •37: Tumors of the Penis
- •Questions
- •Answers
- •38: Tumors of the Urethra
- •Questions
- •Answers
- •39: Inguinal Node Dissection
- •Questions
- •Answers
- •40: Surgery of the Penis and Urethra
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •47: Renal Transplantation
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •50: Upper Urinary Tract Trauma
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •53: Strategies for Nonmedical Management of Upper Urinary Tract Calculi
- •Questions
- •Answers
- •54: Surgical Management for Upper Urinary Tract Calculi
- •Questions
- •Answers
- •55: Lower Urinary Tract Calculi
- •Questions
- •Answers
- •56: Benign Renal Tumors
- •Questions
- •Answers
- •57: Malignant Renal Tumors
- •Questions
- •Answers
- •Questions
- •Answers
- •59: Retroperitoneal Tumors
- •Questions
- •Answers
- •60: Open Surgery of the Kidney
- •Questions
- •Answers
- •Questions
- •Answers
- •62: Nonsurgical Focal Therapy for Renal Tumors
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •66: Surgery of the Adrenal Glands
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •71: Evaluation and Management of Women with Urinary Incontinence and Pelvic Prolapse
- •Questions
- •Answers
- •72: Evaluation and Management of Men with Urinary Incontinence
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •76: Overactive Bladder
- •Questions
- •Answers
- •77: Underactive Detrusor
- •Questions
- •Answers
- •78: Nocturia
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •82: Retropubic Suspension Surgery for Incontinence in Women
- •Questions
- •Answers
- •83: Vaginal and Abdominal Reconstructive Surgery for Pelvic Organ Prolapse
- •Questions
- •Answers
- •Questions
- •Answers
- •85: Complications Related to the Use of Mesh and Their Repair
- •Questions
- •Answers
- •86: Injection Therapy for Urinary Incontinence
- •Questions
- •Answers
- •87: Additional Therapies for Storage and Emptying Failure
- •Questions
- •Answers
- •88: Aging and Geriatric Urology
- •Questions
- •Answers
- •89: Urinary Tract Fistulae
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •92: Tumors of the Bladder
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •95: Transurethral and Open Surgery for Bladder Cancer
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •99: Orthotopic Urinary Diversion
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Answers
- •Questions
- •Answers
- •108: Prostate Cancer Tumor Markers
- •Questions
- •Answers
- •Questions
- •110: Pathology of Prostatic Neoplasia
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •114: Open Radical Prostatectomy
- •Questions
- •Answers
- •Questions
- •Answers
- •116: Radiation Therapy for Prostate Cancer
- •Questions
- •Answers
- •117: Focal Therapy for Prostate Cancer
- •Questions
- •Answers
- •Questions
- •Answers
- •119: Management of Biomedical Recurrence Following Definitive Therapy for Prostate Cancer
- •Questions
- •Answers
- •120: Hormone Therapy for Prostate Cancer
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •124: Perinatal Urology
- •Questions
- •Answers
- •Questions
- •Answers
- •126: Pediatric Urogenital Imaging
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •133: Surgery of the Ureter in Children
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •137: Vesicoureteral Reflux
- •Questions
- •Answers
- •138: Bladder Anomalies in Children
- •Questions
- •Answers
- •139: Exstrophy-Epispadias Complex
- •Questions
- •Answers
- •140: Prune-Belly Syndrome
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •144: Management of Defecation Disorders
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •147: Hypospadias
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •152: Adolescent and Transitional Urology
- •Questions
- •Answers
- •Questions
- •Answers
- •154: Pediatric Genitourinary Trauma
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
51
Urinary Lithiasis
Etiology, Epidemiology, and Pathogenesis
Margaret S. Pearle; Jodi A. Antonelli; Yair Lotan
Questions
1.The ethnic/racial group with the highest prevalence of stone disease is:
a.African-Americans.
b.Hispanics.
c.Whites.
d.Asians.
e.American Indians.
2.The geographic area in the United States associated with the highest incidence of calcium oxalate stone disease is the:
a.northeast.
b.southeast.
c.southwest.
d.west.
e.northwest.
3.Which of the following occurs when the concentration product of urine is in the metastable range?
a.Urine is supersaturated.
b.Homogeneous nucleation occurs.
c.Solubility product is reduced.
d.Urinary inhibitors decrease the formation product.
e.Nucleation never occurs.
4.The process by which nucleation occurs in pure solutions is:
a.homogeneous nucleation.
b.heterogeneous nucleation.
c.epitaxy.
d.aggregation.
e.agglomeration.
5.The proteinaceous portion of stones is composed of:
a.concentric lamination.
b.protein-crystal complex.
c.matrix.
d.nephrocalcin.
e.osteocalcin.
6.Citrate inhibits calcium oxalate stone formation by:
a.binding urinary inhibitors.
b.lowering urine magnesium levels.
c.increasing urinary saturation of sodium urate.
d.complexing calcium.
e.lowering urine pH.
7.Stone-forming propensity is best described by:
a.formation product.
b.ionic activity.
c.saturation index.
d.solubility product.
e.relative saturation ratio.
8.The most common abnormal urinary finding in patients undergoing Roux-en- Y gastric bypass surgery is:
a.hypercalciuria.
b.low urine pH.
c.low urine volume.
d.hypocitraturia.
e.hyperoxaluria.
9.The vitamin D metabolite that stimulates intestinal calcium absorption is:
a.7-dehydrocholesterol.
b.cholecalciferol.
c.25-dihydroxyvitamin D3.
d.1,25-dihydroxyvitamin D3.
e.calcitonin.
.Which of the following factors increases intestinal oxalate absorption? a. High dietary calcium intake
b.Low dietary calcium intake
c.Oxalobacter formigenes colonization in the colon
d.Helicobacter pylori colonization in the stomach
e.Irritable bowel syndrome
.The primary determinant of urinary citrate excretion is:
a.acid-base status.
b.urinary sodium excretion.
c.citric acid intake.
d.insulin sensitivity.
e.urinary calcium excretion.
.The underlying abnormality of renal hypercalciuria is:
a.enhanced calcium filtration.
b.enhanced calcium secretion.
c.enhanced calcium reabsorption.
d.primary renal wasting of calcium.
e.primary renal storage of calcium.
.Hypercalciuria associated with sarcoidosis is a result of:
a.absorptive hypercalciuria.
b.renal hypercalciuria.
c.resorptive hypercalciuria.
d.acidosis.
e.medical induction.
.Enteric hyperoxaluria occurs as a result of:
a.excessive intake of oxalate.
b.reduced excretion of oxalate.
c.increased dietary fat.
d.low calcium intake.
e.fat malabsorption.
.The most likely mechanism accounting for low urinary pH in uric acid stone formers with type 2 diabetes mellitus is:
a.defective ammoniagenesis.
b.impaired urinary bicarbonate excretion.
c.lactic acidosis.
d.glucosuria.
e.ketoacidosis.
.In idiopathic calcium oxalate stone formers, Randall plaques originate in the: a. basement membrane of the thin loops of Henle.
b.terminal collecting ducts.
c.medullary interstitium.
d.vasa recta.
e.papillary tip.
.In calcium oxalate stone formers, Randall plaques are composed of:
a.calcium oxalate.
b.brushite.
c.calcium carbonate.
d.calcium apatite.
e.uric acid.
.Urinary saturation of calcium oxalate is most strongly dependent on:
a.Urinary calcium concentration
b.Urinary oxalate concentration
c.Both urinary calcium and oxalate concentrations
d.Urinary pH
e.Urinary citrate concentration
.O. formigenes reduces urinary oxalate by:
a.reducing intestinal calcium absorption, leading to decreased luminal free oxalate and reduced oxalate absorption.
b.degrading urinary oxalate in infected urine.
c.binding oxalate in the intestinal lumen and preventing its reabsorption.
d.inhibiting the intestinal oxalate transporter.
e.using oxalate as a substrate in the intestine, thereby reducing intestinal oxalate absorption.
.Which of the following organisms is most likely to produce urease?
a.Staphylococcus aureus
b.Escherichia coli
c.Streptococcus pneumoniae
d.Serratia marcescens
e.Chlamydia
.The mechanism responsible for type 1 (distal) renal tubular acidosis (RTA) is:
a.impaired bicarbonate reabsorption in the proximal tubule.
b.defective H+-ATPase in the distal tubule that is unable to excrete excess acid.
c.defective ammoniagenesis.
d.impaired excretion of nontitratable acids.
e.hypoaldosteronism.
.Patients with Lesch-Nyhan syndrome treated with high doses of allopurinol are at risk for formation of stones of which of the following compositions?
a.Hypoxanthine
b.Uric acid
c.Xanthine
d.2,8-Dihydroxyadenine
e.Calcium apatite
.The etiology of ammonium acid urate stone formation in patients abusing laxatives is:
a.recurrent infections with urease-producing bacteria.
b.chronic dehydration and excessive uric acid excretion.
c.increased ammoniagenesis.
d.urinary phosphate deficiency and intracellular acidosis.
e.chronic dehydration, intracellular acidosis, and low urinary sodium.
.The primary mechanism of action of citrate in preventing stone formation is:
a.reducing urinary calcium excretion.
b.reducing urinary oxalate excretion.
c.complexing calcium in urine.
d.complexing oxalate in urine.
e.complexing phosphate in urine.
.Type 1 (distal) RTA is characterized by which abnormality?
a.Hyperkalemia
b.Hypochloremia
c.Alkalosis
d.Hypercitraturia
e.Hypokalemia
.The primary defect in type 2 (proximal) RTA is failure of bicarbonate reabsorption in the:
a.glomerulus.
b.proximal tubule.
c.loop of Henle.
d.distal tubule.
e.collecting duct.
.The most common abnormality identified in patients with uric acid stones is:
a.acidic urine.
b.alkaline urine.
c.low uric acid concentration.